CTI BioPharma Corp. appointed Michael Metzger as a board member.
Metzger is currently president and COO of Syndax Pharmaceuticals Inc.
Discover more about S&P Global’s offerings
CTI BioPharma adds Syndax COO to board
Essential IR Insights Newsletter Fall - 2023
A Corporation Clearly Pinpoints Activist Investor Activity
Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise
Insight Weekly: US companies boost liquidity; auto insurers hike rates; office sector risk rises
CTI BioPharma Corp. appointed Michael Metzger as a board member.
Metzger is currently president and COO of Syndax Pharmaceuticals Inc.